The U.S. Food and Drug Administration granted approval to Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as supplementary treatments to diet and exercise. These medications aim to enhance blood sugar control in children aged 10 years and above who are diagnosed with type 2 diabetes. This recent approval signifies ...
Read More »Impact of Canadian Wildfire Smoke: Hazy Skies and Unhealthy Air Quality Engulf New York City
The air quality in New York City has plummeted to alarming levels this week due to the southward drift of smoke originating from raging wildfires in Canada. According to AirNow, the U.S. government’s online platform, the air quality index across all five boroughs exceeded 150 on Tuesday. These levels are ...
Read More »FDA Gives Approval to New Drug for Treating Menopause-Related Moderate to Severe Hot Flashes
The FDA has granted approval for Veozah (fezolinetant), an oral medication designed to treat moderate to severe vasomotor symptoms, including hot flashes, associated with menopause. This marks the first FDA-approved neurokinin 3 (NK3) receptor antagonist for treating hot flashes caused by menopause. Veozah functions by binding to and inhibiting the ...
Read More »COVID-19 Global Emergency Ends as Declared by WHO
After more than three years since the COVID-19 pandemic emerged, the World Health Organization declared on Friday that it is no longer a global public health emergency. During a press conference on Friday, WHO Director-General Tedros Adhanom Ghebreyesus declared that COVID-19 is no longer a global health emergency with optimism. ...
Read More »Tips for Gradually Reintroducing Exercise after Surgery
One surgeon advises patients who have undergone surgery to gradually reintroduce movement and exercise. Even small efforts can be beneficial, and it is crucial to pay attention to your body and its limitations. Dr. Adil Ahmed, an assistant professor in the Department of Orthopedic Surgery at Baylor College of Medicine ...
Read More »FDA Approves Simplified Use of Bivalent mRNA COVID-19 Vaccines
The U.S. Food and Drug Administration has modified the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines, making the vaccination schedule simpler for most people. The revised EUAs authorize the use of the current bivalent vaccines (original and omicron BA.4/BA.5 strains) for all doses given ...
Read More »FDA Approves Spring COVID-19 Booster Shot for Eligible Americans
The U.S. Food and Drug Administration declared on Tuesday that individuals who are seniors or have compromised immune systems can receive an additional dose of the bivalent COVID-19 vaccine during this spring. According to the FDA, individuals who are 65 years and older can receive a booster shot of the ...
Read More »Moderna aims to introduce novel vaccines for cancer, heart disease, and other ailments by 2030
On Monday, a spokesperson for Moderna confirmed to CNBC that the company aims to develop new vaccines to target cancer, heart disease, and other illnesses by 2030. This follows comments made by the company’s chief medical officer, Dr. Paul Burton, to The Guardian on Saturday, expressing his confidence that these ...
Read More »FDA Commissioner and Chief Scientist Declare Withdrawal of Makena Approval
On Thursday, The U.S. Food and Drug Administration (FDA) announced its final decision to withdraw the approval of Makena, a drug that was granted approval through the accelerated approval pathway. Makena was originally approved to decrease the risk of preterm birth in pregnant women with a history of spontaneous preterm ...
Read More »Pfizer’s Paxlovid shows potential in reducing risk of long Covid, study
New research indicates that individuals who take Pfizer’s Covid antiviral drug Paxlovid shortly after contracting the virus may lower their chances of developing long Covid, regardless of their age, vaccination status, or infection history. The findings, published on Thursday in the JAMA Internal Medicine journal, revealed that those who took ...
Read More »
Reports Stack News and Updates